CHOLANGIOCARCINOMA-WHAT LEVEL OF EVIDENCE SHOULD WE HAVE?

被引：1

|

作者：

Abrams, Ross A. ^{[1
]}

机构：

[1] Rush Univ, Med Ctr, Dept Radiat Oncol, Chicago, IL 60612 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 73卷 / 01期

关键词：

BILE-DUCT; CHEMORADIOTHERAPY; ADENOCARCINOMA;

D O I：

10.1016/j.ijrobp.2008.08.041

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：1 / 2

页数：2

相关论文

共 50 条

[31] Glycemic control: What level should we reach?
Ahmed, Almoutaz Alkhier
Alsharief, Emad
Alsharief, Ali
WORLD FAMILY MEDICINE, 2013, 11 (05): : 36 - 40
[32] A process control retrospective; What we should have done
Bristol, EH
ISA 2002 TECHNOLOGY UPDATE, VOL LVII, PT 1, 2002, 422 : 255 - 262
[33] History lesson - What we should have known.
Peretz, M
NEW REPUBLIC, 2004, 230 (24) : 25 - 27
[34] PCSK9 inhibitors: what we know, what we should have understood, and what is to come
Sabatine, Marc S.
EUROPEAN HEART JOURNAL, 2022, 43 (07) : E29 - E31
[35] Antifungals: what we have, what we will have, what we want
Martinez-Mendez, Dilia
Bravo-Acosta, Mariolga
Semprun-Hernandez, Neomar
INVESTIGACION CLINICA, 2023, 64 (04): : 539 - 556
[36] What are we? What should we be?
Leung, Gabriel M.
Gray, Selena
JOURNAL OF PUBLIC HEALTH, 2012, 34 (04) : 475 - 476
[37] What we do, what we should do, and what we should not do
Ernst, E
ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2001, 7 (04) : 36 - +
[38] Where has evidence come from, what do we have now and what will we have in the future?
Thomson, A
MIDWIFERY, 2003, 19 (01) : 1 - 2
[39] WE HAVE WHAT WE HAVE
Krupyna, V
AB IMPERIO-STUDIES OF NEW IMPERIAL HISTORY AND NATIONALISM IN THE POST-SOVIET SPACE, 2016, (03): : 392 - 399
[40] What have we acquired and what should we acquire in divestiture research? A review and research agenda
Brauer, Matthias
JOURNAL OF MANAGEMENT, 2006, 32 (06) : 751 - 785

← 1 2 3 4 5 →